BLACKBERRY LTD (BB)

CA09228F1036 - Common Stock

2.89  +0.09 (+3.21%)

After market: 2.9 +0.01 (+0.35%)

Fundamental Rating

3

Overall BB gets a fundamental rating of 3 out of 10. We evaluated BB against 276 industry peers in the Software industry. BB has a bad profitability rating. Also its financial health evaluation is rather negative. BB is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

BB had positive earnings in the past year.
BB had a negative operating cash flow in the past year.
BB had negative earnings in 4 of the past 5 years.
In multiple years BB reported negative operating cash flow during the last 5 years.

1.2 Ratios

BB's Return On Assets of -9.32% is in line compared to the rest of the industry. BB outperforms 47.81% of its industry peers.
The Return On Equity of BB (-16.75%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -9.32%
ROE -16.75%
ROIC N/A
ROA(3y)-17.52%
ROA(5y)-19.13%
ROE(3y)-33.88%
ROE(5y)-36.21%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 60.96%, BB perfoms like the industry average, outperforming 43.43% of the companies in the same industry.
In the last couple of years the Gross Margin of BB has declined.
BB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.4%
GM growth 5Y-4.67%

3

2. Health

2.1 Basic Checks

BB does not have a ROIC to compare to the WACC, probably because it is not profitable.
BB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BB has been increased compared to 5 years ago.
Compared to 1 year ago, BB has an improved debt to assets ratio.

2.2 Solvency

BB has an Altman-Z score of 0.14. This is a bad value and indicates that BB is not financially healthy and even has some risk of bankruptcy.
BB has a Altman-Z score of 0.14. This is in the lower half of the industry: BB underperforms 69.71% of its industry peers.
BB has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
BB has a Debt to Equity ratio (0.25) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 0.14
ROIC/WACCN/A
WACC8.36%

2.3 Liquidity

BB has a Current Ratio of 1.43. This is a normal value and indicates that BB is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.43, BB perfoms like the industry average, outperforming 44.89% of the companies in the same industry.
A Quick Ratio of 1.43 indicates that BB should not have too much problems paying its short term obligations.
The Quick ratio of BB (1.43) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.43

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 135.29% over the past year.
The earnings per share for BB have been decreasing by -23.57% on average. This is quite bad
The Revenue has grown by 30.03% in the past year. This is a very strong growth!
BB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.15% yearly.
EPS 1Y (TTM)135.29%
EPS 3Y-30.66%
EPS 5Y-23.57%
EPS growth Q2Q250%
Revenue 1Y (TTM)30.03%
Revenue growth 3Y-1.52%
Revenue growth 5Y-1.15%
Revenue growth Q2Q14.57%

3.2 Future

BB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.15% yearly.
BB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.24% yearly.
EPS Next Y-134.33%
EPS Next 2Y-19.77%
EPS Next 3Y23.6%
EPS Next 5Y49.15%
Revenue Next Year-23.99%
Revenue Next 2Y-9.38%
Revenue Next 3Y3.24%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 48.17, the valuation of BB can be described as expensive.
65.33% of the companies in the same industry are more expensive than BB, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.20, BB is valued quite expensively.
BB is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 48.17
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BB is valued a bit cheaper than the industry average as 64.96% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 72.63

4.3 Compensation for Growth

BB's earnings are expected to grow with 23.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.77%
EPS Next 3Y23.6%

0

5. Dividend

5.1 Amount

No dividends for BB!.
Industry RankSector Rank
Dividend Yield N/A

BLACKBERRY LTD

NYSE:BB (4/23/2024, 7:04:00 PM)

After market: 2.9 +0.01 (+0.35%)

2.89

+0.09 (+3.21%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.70B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 48.17
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.32%
ROE -16.75%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 60.96%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.43
Quick Ratio 1.43
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)135.29%
EPS 3Y-30.66%
EPS 5Y
EPS growth Q2Q
EPS Next Y-134.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)30.03%
Revenue growth 3Y-1.52%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y